- Home
- RGEN vs ESE Comparison
RGEN vs ESE Comparison
Compare RGEN & ESE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGEN
- ESE
- Stock Information
- Founded
- RGEN 1981
- ESE 1990
- Country
- RGEN United States
- ESE United States
- Employees
- RGEN N/A
- ESE N/A
- Industry
- RGEN Medical/Dental Instruments
- ESE Telecommunications Equipment
- Sector
- RGEN Health Care
- ESE Telecommunications
- Exchange
- RGEN Nasdaq
- ESE Nasdaq
- Market Cap
- RGEN 6.5B
- ESE 5.4B
- IPO Year
- RGEN N/A
- ESE N/A
- Fundamental
- Price
- RGEN $119.75
- ESE $210.48
- Analyst Decision
- RGEN Buy
- ESE Strong Buy
- Analyst Count
- RGEN 10
- ESE 2
- Target Price
- RGEN $163.78
- ESE $187.50
- AVG Volume (30 Days)
- RGEN 706.1K
- ESE 235.2K
- Earning Date
- RGEN 11-11-2025
- ESE 11-13-2025
- Dividend Yield
- RGEN N/A
- ESE 0.15%
- EPS Growth
- RGEN N/A
- ESE 14.55
- EPS
- RGEN N/A
- ESE 4.43
- Revenue
- RGEN $673,956,000.00
- ESE $1,123,852,000.00
- Revenue This Year
- RGEN $16.74
- ESE $17.55
- Revenue Next Year
- RGEN $13.86
- ESE $12.43
- P/E Ratio
- RGEN N/A
- ESE $47.19
- Revenue Growth
- RGEN 8.73
- ESE 22.39
- 52 Week Low
- RGEN $102.97
- ESE $118.96
- 52 Week High
- RGEN $182.52
- ESE $211.25
- Technical
- Relative Strength Index (RSI)
- RGEN 50.04
- ESE 65.50
- Support Level
- RGEN $112.73
- ESE $200.19
- Resistance Level
- RGEN $122.71
- ESE $210.79
- Average True Range (ATR)
- RGEN 4.63
- ESE 4.68
- MACD
- RGEN -0.46
- ESE 0.81
- Stochastic Oscillator
- RGEN 55.87
- ESE 95.52
About RGEN Repligen Corporation
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.
About ESE ESCO Technologies Inc.
ESCO Technologies Inc sells engineered products and systems for utility, industrial, aerospace, and commercial applications. The firm operates in three segments: Aerospace and Defense, Utility Solutions Group (USG), and Test. The Aerospace and Defense segment designs and manufactures specialty filtration and naval products. The USG segment provides diagnostic testing solutions. The Test segment provides its customers with the ability to identify, measure, and contain magnetic, electromagnetic, and acoustic energy.